drugset / Trial / NCT03000413

Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial

NCT03000413

Phase 2/3 Completed 45 enrolled Hospital Nossa Senhora da Conceicao
RandomizedParallel-groupDouble-blindTreatment

Summary

Despite few scientific evidence that could support the use of ketamine in adult patients undergoing acute bronchospasm requiring mechanical ventilation (MV), ketamine is largely employed in this setting. The aim of this study is therefore assess more definitively the real benefit of using ketamine in patients with severe bronchospasm, requiring ICU stay and need for MV in order to establish or refute the use of this drug as "standard therapy" in these cases.

Timeline

Start
2015-06-04
Primary completion
2017-06-16
Completion
2018-01-29

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 1 ug/kg
Subject Ketamine Small molecule 2 mg/kg Intravenous

Indications